M&T Bank Corp Charles River Laboratories International, Inc. Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 1,935 shares of CRL stock, worth $373,261. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,935

Previous 2,213 12.56%

Holding current value

$373,261

Previous $599,000 33.39%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$206.39 - $268.73 $57,376 - $74,706	-278 Reduced 12.56%	1,935 $399,000
Q1 2024 May 07, 2024	BUY	$203.52 - $273.43 $59,834 - $80,388	294 Added 15.32%	2,213 $599,000
Q4 2023 Feb 06, 2024	SELL	$164.52 - $238.84 $25,829 - $37,497	-157 Reduced 7.56%	1,919 $453,000
Q3 2023 Nov 02, 2023	BUY	$194.44 - $217.61 $12,833 - $14,362	66 Added 3.28%	2,076 $406,000
Q2 2023 Aug 09, 2023	SELL	$183.71 - $210.25 $11,022 - $12,615	-60 Reduced 2.9%	2,010 $422,000
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $11,897 - $16,115	-62 Reduced 2.91%	2,070 $417,000
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $4.81 Million - $6.1 Million	-24,386 Reduced 91.96%	2,132 $464,000
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $4.82 Million - $6.12 Million	24,476 Added 1198.63%	26,518 $5.78 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $117,126 - $160,846	-642 Reduced 23.92%	2,042 $347,000
Q2 2022 Aug 05, 2022	BUY	$204.13 - $302.4 $162,079 - $240,105	794 Added 42.01%	2,684 $478,000
Q1 2022 May 09, 2022	BUY	$255.51 - $362.11 $90,450 - $128,186	354 Added 23.05%	1,890 $535,000
Q4 2021 Feb 07, 2022	BUY	$351.38 - $448.68 $38,300 - $48,906	109 Added 7.64%	1,536 $578,000
Q3 2021 Oct 28, 2021	SELL	$372.64 - $458.3 $78,254 - $96,243	-210 Reduced 12.83%	1,427 $590,000
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $53,538 - $67,640	-182 Reduced 10.01%	1,637 $605,000
Q1 2021 May 06, 2021	SELL	$249.67 - $299.48 $93,126 - $111,706	-373 Reduced 17.02%	1,819 $527,000
Q4 2020 Feb 12, 2021	SELL	$222.0 - $252.62 $36,852 - $41,934	-166 Reduced 7.04%	2,192 $547,000
Q3 2020 Nov 06, 2020	SELL	$175.56 - $226.45 $14,747 - $19,021	-84 Reduced 3.44%	2,358 $534,000
Q2 2020 Jul 29, 2020	SELL	$118.84 - $189.72 $53,596 - $85,563	-451 Reduced 15.59%	2,442 $427,000
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $791 - $1,426	8 Added 0.28%	2,893 $365,000
Q4 2019 Feb 07, 2020	BUY	$126.05 - $152.76 $27,226 - $32,996	216 Added 8.09%	2,885 $440,000
Q3 2019 Nov 12, 2019	SELL	$125.07 - $143.67 $3,001 - $3,448	-24 Reduced 0.89%	2,669 $353,000
Q2 2019 Aug 12, 2019	SELL	$123.4 - $148.55 $115,625 - $139,191	-937 Reduced 25.81%	2,693 $381,000
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $37,944 - $53,116	-362 Reduced 9.07%	3,630 $527,000
Q4 2018 Feb 01, 2019	SELL	$105.09 - $137.23 $1,681 - $2,195	-16 Reduced 0.4%	3,992 $453,000
Q3 2018 Nov 09, 2018	BUY	$112.11 - $134.54 $34,081 - $40,900	304 Added 8.21%	4,008 $539,000
Q2 2018 Aug 10, 2018	BUY	$102.37 - $117.25 $15,253 - $17,470	149 Added 4.19%	3,704 $416,000
Q1 2018 May 04, 2018	SELL	$98.19 - $115.2 $2,552 - $2,995	-26 Reduced 0.73%	3,555 $379,000
Q4 2017 Feb 06, 2018	SELL	$100.43 - $118.09 $7,431 - $8,738	-74 Reduced 2.02%	3,581 $392,000
Q3 2017 Nov 13, 2017	SELL	$96.72 - $109.26 $67,994 - $76,809	-703 Reduced 16.13%	3,655 $395,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,358	4,358 $441,000

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.81B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account